XOMA (XOMA) Announces XMetA Study Demonstrates Potential to Improve Glycemic Control In Vivo
Go back to XOMA (XOMA) Announces XMetA Study Demonstrates Potential to Improve Glycemic Control In Vivo| XOMA (NASDAQ: XOMA) | Delayed: 40.17 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $40.17 | 52 Week High | $7.33 | |||
| Open | $40.17 | 52 Week Low | $0.34 | |||
| Day High | $40.17 | P/E | N/A | |||
| Day Low | $40.17 | EPS | $-0.73 | |||
| Volume | 1,637,994 | |||||
